• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童感染相关性噬血细胞性淋巴组织细胞增生症的关键危险因素分析

Critical risk factors analysis of infection-associated hemophagocytic lymphohistiocytosis in children.

作者信息

Hao Gailing, Geng Wenjin, Li Chunzhen, Li Quanheng, Zhang Nan, Jiang Lian

机构信息

Department of Emergency Medicine, Hebei Children's Hospital Affiliated to Hebei Medical University, Shijiazhuang, Hebei, China.

Department of Qenal Immunology, Hebei Children's Hospital Affiliated to Hebei Medical University, Shijiazhuang, Hebei, China.

出版信息

Ann Hematol. 2025 Jan;104(1):111-121. doi: 10.1007/s00277-024-06058-3. Epub 2024 Nov 4.

DOI:10.1007/s00277-024-06058-3
PMID:39495283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11868128/
Abstract

To analyze the critical factors of infection-associated Hemophagocytic lymphohistiocytosis (HLH) in children, so as to provide theoretical basis for clinicians to evaluate the disease condition, formulate treatment plan and improve prognosis. This study is a retrospective analysis. 60 cases of children with infection-associated HLH were divided into critical and non-critical groups based on the presence of multiple organ dysfunction syndrome (MODS), and the clinical characteristics and laboratory data of the two groups of children were analyzed. A multifactor logistic regression analysis model was used to assess the independent risk factors affecting critical illness in children with infection-associated HLH, and the Receiver Operating Characteristic (ROC) curve analysis was used to evaluate the predictive value of risk factors for critical illness in children with infection-associated HLH. Children in the critical group with HLH had a younger age at onset. Alanine aminotransferase (ALT), aspartate aminotransferase (AST), lactate dehydrogenase (LDH), gamma-glutamyl transferase (GGT), D-dimer (DD), and triglycerides (TG) were significantly higher in the critical group, while albumin (ALB) was significantly lower, showing statistical significance (P < 0.05). Multifactorial logistic regression analysis of age, ALB, and TG showed that younger age and lower ALB were associated with a higher risk of MODS in children with infection-associated HLH, with age and ALB being independent risk factors for critical illness. ALB predicted the ROC area under the curve for critical children with infection-associated HLH was 0.765 (95% CI: 0.643-0.888, P = 0.011), with the optimal cut-off value being 32.50 g/L (sensitivity = 68.3%, specificity = 84.2%); age predicted the ROC area under the curve for critical children with infection-associated HLH was 0.711 (95% CI: 0.570-0.851, P = 0.009), with the optimal cut-off value being 1.50 years (sensitivity = 70.7%, specificity = 68.4%). This study suggests that younger patients and those with hypoalbuminemia among infection-related HLH patients are more likely to develop MODS. In the future, verification will be required through large-scale, multi-center studies.

摘要

分析儿童感染相关性噬血细胞性淋巴组织细胞增生症(HLH)的感染相关关键因素,为临床医生评估病情、制定治疗方案及改善预后提供理论依据。本研究为回顾性分析。将60例感染相关性HLH患儿根据是否存在多器官功能障碍综合征(MODS)分为危重症组和非危重症组,分析两组患儿的临床特征及实验室数据。采用多因素logistic回归分析模型评估影响感染相关性HLH患儿危重症的独立危险因素,并采用受试者工作特征(ROC)曲线分析评估危险因素对感染相关性HLH患儿危重症的预测价值。HLH危重症组患儿发病年龄较小。危重症组患儿的丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)、乳酸脱氢酶(LDH)、γ-谷氨酰转移酶(GGT)、D-二聚体(DD)及甘油三酯(TG)显著升高,而白蛋白(ALB)显著降低,差异具有统计学意义(P<0.05)。对年龄、ALB及TG进行多因素logistic回归分析显示,年龄较小及ALB较低与感染相关性HLH患儿发生MODS的风险较高相关,年龄和ALB为危重症的独立危险因素。ALB预测感染相关性HLH危重症患儿的ROC曲线下面积为0.765(95%CI:0.643-0.888,P=0.011),最佳截断值为32.50g/L(灵敏度=68.3%,特异度=84.2%);年龄预测感染相关性HLH危重症患儿的ROC曲线下面积为0.711(95%CI:0.570-0.851,P=0.009),最佳截断值为1.50岁(灵敏度=70.7%,特异度=68.4%)。本研究提示,感染相关性HLH患者中年龄较小及低白蛋白血症患者更易发生MODS。未来需通过大规模、多中心研究进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/87dd3eb9c827/277_2024_6058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/39a8ccda66f1/277_2024_6058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/fdc4630e8130/277_2024_6058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/87dd3eb9c827/277_2024_6058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/39a8ccda66f1/277_2024_6058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/fdc4630e8130/277_2024_6058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b73/11868128/87dd3eb9c827/277_2024_6058_Fig3_HTML.jpg

相似文献

1
Critical risk factors analysis of infection-associated hemophagocytic lymphohistiocytosis in children.儿童感染相关性噬血细胞性淋巴组织细胞增生症的关键危险因素分析
Ann Hematol. 2025 Jan;104(1):111-121. doi: 10.1007/s00277-024-06058-3. Epub 2024 Nov 4.
2
Clinical laboratory Analysis of EB Virus Associated Hemophagocytic Lymphohistiocytosis in Children.儿童 EB 病毒相关性噬血细胞性淋巴组织细胞增生症的临床实验室分析。
Altern Ther Health Med. 2024 May;30(5):148-154.
3
[Clinical Crrelation and Prognostic Analysis of ALBI Score in Secondary Hemophagocytic Syndrome in Children].[儿童继发性噬血细胞综合征中ALBI评分的临床相关性及预后分析]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2024 Oct;32(5):1585-1593. doi: 10.19746/j.cnki.issn.1009-2137.2024.05.044.
4
[Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].[老年重症新型冠状病毒肺炎患者继发噬血细胞性淋巴组织细胞增生症的临床特征及危险因素:一项多中心回顾性队列研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):793-799. doi: 10.3760/cma.j.cn121430-20230510-00158.
5
Clinical characteristics of hemophagocytic lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症的临床特征。
Technol Health Care. 2024;32(4):2509-2526. doi: 10.3233/THC-231275.
6
Study on ferritin and liver injury in pediatric hemophagocytic lymphohistiocytosis associated with infection.感染相关小儿噬血细胞性淋巴组织细胞增生症中铁蛋白与肝损伤的研究
Sci Rep. 2025 Apr 12;15(1):12662. doi: 10.1038/s41598-025-96533-2.
7
Predicting 30-day mortality in hemophagocytic lymphohistiocytosis: clinical features, biochemical parameters, and machine learning insights.噬血细胞性淋巴组织细胞增生症30天死亡率的预测:临床特征、生化参数及机器学习见解
Ann Hematol. 2025 Apr;104(4):2239-2264. doi: 10.1007/s00277-025-06249-6. Epub 2025 Mar 1.
8
Pre-diagnostic trajectory of pediatric hemophagocytic lymphohistiocytosis: observations from hematological and hepatic parameters.儿童噬血细胞性淋巴组织细胞增生症的诊断前轨迹:血液学和肝脏参数观察
Ann Hematol. 2024 Dec;103(12):5145-5155. doi: 10.1007/s00277-024-06073-4. Epub 2024 Oct 27.
9
Outcome analysis of pediatric hemophagocytic lymphohistiocytosis.小儿噬血细胞性淋巴组织细胞增生症的疗效分析。
J Formos Med Assoc. 2021 Jan;120(1 Pt 1):172-179. doi: 10.1016/j.jfma.2020.03.025. Epub 2020 Apr 16.
10
Hypoalbuminaemia is an independent predictor for hemophagocytic lymphohistiocytosis in childhood Epstein-Barr virus-associated infectious mononucleosis.低蛋白血症是儿童 EBV 相关传染性单核细胞增多症噬血细胞性淋巴组织细胞增生症的独立预测因子。
Eur J Haematol. 2012 Nov;89(5):417-22. doi: 10.1111/ejh.12006. Epub 2012 Sep 7.

本文引用的文献

1
Clinical Features of Hepatic Manifestations among Adult Patients with Hemophagocytic Lymphohistiocytosis: A Retrospective Study.成人噬血细胞性淋巴组织细胞增生症患者肝脏表现的临床特征:一项回顾性研究
Acta Haematol. 2024;147(5):525-533. doi: 10.1159/000535535. Epub 2024 Jan 16.
2
The Liver in Hemophagocytic Lymphohistiocytosis: Not an Innocent Bystander.噬血细胞性淋巴组织细胞增生症中的肝脏:并非无辜的旁观者。
J Pediatr Gastroenterol Nutr. 2023 Aug 1;77(2):153-159. doi: 10.1097/MPG.0000000000003807. Epub 2023 Apr 25.
3
Fulfillment status of hypertriglyceridemia and hypofibrinogenemia in children with hemophagocytic lymphohistiocytosis and risks of multiple organ dysfunction syndrome and early mortality.
噬血细胞性淋巴组织细胞增生症患儿高甘油三酯血症和低纤维蛋白原血症的转归及多器官功能障碍综合征和早期死亡的风险。
Orphanet J Rare Dis. 2022 Apr 11;17(1):161. doi: 10.1186/s13023-022-02315-8.
4
Clinical Features and Prognostic Factors of Early Outcome in Pediatric Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis of 227 Cases.儿童噬血细胞性淋巴组织细胞增生症的临床特征和预后因素:227 例回顾性分析。
J Pediatr Hematol Oncol. 2022 Jan 1;44(1):e217-e222. doi: 10.1097/MPH.0000000000002283.
5
Hemophagocytic Lymphohistiocytosis.噬血细胞性淋巴组织细胞增生症
Arch Pathol Lab Med. 2022 Apr 1;146(4):507-519. doi: 10.5858/arpa.2020-0802-RA.
6
Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus.临床警惕 EBV 所致噬血细胞综合征
Ital J Pediatr. 2021 Jan 7;47(1):3. doi: 10.1186/s13052-020-00949-7.
7
Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center.儿童恶性肿瘤相关噬血细胞性淋巴组织细胞增生症:单儿科血液病中心 10 年经验。
Hematology. 2020 Dec;25(1):389-399. doi: 10.1080/16078454.2020.1833505.
8
Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy.噬血细胞性淋巴组织细胞增生症:发病机制、诊断和治疗的最新进展。
Best Pract Res Clin Rheumatol. 2020 Aug;34(4):101515. doi: 10.1016/j.berh.2020.101515. Epub 2020 May 7.
9
Hemophagocytic Lymphohistiocytosis in Patients With Primary Immunodeficiency.原发性免疫缺陷患者的噬血细胞性淋巴组织细胞增生症
J Pediatr Hematol Oncol. 2020 Aug;42(6):e434-e439. doi: 10.1097/MPH.0000000000001803.
10
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).噬血细胞性淋巴组织细胞增生症诊断中的挑战:北美组织细胞增生症联盟(NACHO)的建议。
Pediatr Blood Cancer. 2019 Nov;66(11):e27929. doi: 10.1002/pbc.27929. Epub 2019 Jul 24.